Glycerin suppositories used prophylactically in premature infants (SUPP) trial: a study protocol for a pilot randomized controlled trial

Michael H Livingston, Jorge Zequeira, Henrietta Blinder, Julia Pemberton, Connie Williams, J Mark Walton, Michael H Livingston, Jorge Zequeira, Henrietta Blinder, Julia Pemberton, Connie Williams, J Mark Walton

Abstract

Background: Feeding is a significant challenge for premature infants in the neonatal intensive care unit (NICU). These patients are often treated with glycerin suppositories to stimulate the passage of meconium and prevent feeding intolerance. Unfortunately, the evidence for this practice is inconclusive.

Methods/design: This protocol is for an external pilot study that will assess the feasibility of a superiority, placebo-controlled, parallel-design, multicenter randomized controlled trial. Participants are premature infants treated in a level 3 NICU with a gestational age 24 to 32 weeks and/or birth weight of 500 to 1500 g. Thirty participants will be recruited as part of this external pilot study. Participants will be randomized to glycerin suppository (250 mg) or placebo starting 48 to 72 h after birth and continuing once daily until meconium evacuation is complete or for a maximum of 12 days. The placebo consists of a 250-mg glycerin suppository placed in the diaper rather than the rectum. Study treatments are administered by the charge nurse on duty who is not otherwise involved in patient care. All other clinicians and research personnel will remain blinded. Outcomes for the pilot study are percentage of eligible participants randomized, percentage of infants reaching full enteral feeds, cost, and treatment-related adverse events (rectal bleeding, rectal perforation, and anal fissure).

Discussion: This external pilot study will assess the feasibility of a multicenter randomized controlled trial of glycerin suppositories in premature infants. The subsequent multicenter trial will have sufficient power to determine whether this treatment strategy is associated with decreased time to full enteral feeds.

Trial registration: ClinicalTrials.gov: NCT02153606.

Keywords: Feeding intolerance; Necrotizing enterocolitis; Newborn; Prematurity; Suppository.

Figures

Fig. 1
Fig. 1
Plastic measurement guide to ensure consistent dose of glycerin suppositories
Fig. 2
Fig. 2
Overview of glycerin suppositories used prophylactically in premature infants (SUPP) trial

References

    1. Su B. Optimizing nutrition in preterm infants. Pediatr Neonatol. 2014;55:5–13.
    1. Belfort MB, Rifas-Shiman SL, Sullivan T, Collins CT, McPhee AJ, Ryan P, Kleinman KP, Gillman MW, Gibson RA, Makrides M. Infant growth before and after term: effects on neurodevelopment in preterm infants. Pediatrics. 2011;128:e899.
    1. Sharma R, Hudak ML. A clinical perspective of necrotizing enterocolitis: past, present, and future. Clin Perinatol. 2013;40:27–51.
    1. Raval MV, Hall NJ, Pierro A, Moss RL. Evidence-based prevention and surgical treatment of necrotizing enterocolitis—a review of randomized controlled trials. Semin Pediatr Surg. 2013;22:117–21.
    1. Gardener VA, Walton JM, Chessel L. Refeeding technique in a premature infant with short bowel syndrome. Adv Neonatal Care. 2003;6:258–71.
    1. Al-Harbi K, Walton JM, Gardner V, Chessel L, Fitzgerald P. Mucous fistula refeeding in neonates with short bowel syndrome. J Pediatr Surg. 1999;34:1100–3.
    1. Lucchini R, Bizzarri B, Giampietro S, De Curtis M. Feeding intolerance in preterm infants. How to understand the warning signs. J Matern Fetal Neonatal Med. 2011;24(Suppl 1):72–4.
    1. Morris BH, Miller-Loncar CL, Landry SH, Smith KE, Swank PR, Denson SE. Feeding, medical factors, and developmental outcome in premature infants. Clin Pediatr (Phila) 1999;38:451–7.
    1. Shah V, Chirinian N, Lee S. Does the use of glycerin laxatives decrease feeding intolerance in preterm infants? Paediatr Child Health. 2011;16:e68–70.
    1. Loening-Baucke V, Kimura K. Failure to pass meconium: diagnosing intestinal obstruction. Am Fam Physician. 1990;60:2040–50.
    1. Meetze WH, Franz AR, Linder W, Pohlandt F. Meconium passage in very-low birthweight infants. J Parenter Enteral Nutr. 1993;17:1537–40.
    1. Mihatsch WA, Franz AR, Lindner W, Pohlandt F. Meconium passage in extremely low birthweight infants and its relation to very early enteral nutrition. Acta Paediatr. 2001;90:409–11.
    1. Shim SY, Kim HS, Kim DH, Kim EK, Son DW, Kim BI, et al. Induction of early meconium evacuation promotes feeding tolerance in very low birth weight infants. Neonatology. 2007;92:67-72.
    1. Haiden N, Jilma B, Gerhold B, Klebermass K, Prusa AR, Kuhle S, et al. Small volume enemas do not accelerate meconium evacuation in very low birth weight infants. J Pediatr Gastroenterol Nutr. 2007 Feb;44:270-3.
    1. Khadr SN, Ibhanesebhor SE, Rennix C, Fisher HE, Manjunatha CM, Young D, et al. Randomized controlled trial: impact of glycerin suppositories on time to full feeds in preterm infants. Neonatology. 2011;100:169-76.
    1. Shinde S, Kabra NS, Sharma SR, Avasthi BS, Ahmed J. Glycerin suppository for promoting feeding tolerance in preterm very low birthweight neonates: a randomized controlled trial. Indian Pediatr. 2014;51:367–370.
    1. Livingston MH, Shawyer AC, Rosenbaum PL, Williams C, Jones SA, Walton JM. Glycerin enemas and suppositories in premature infants: a meta-analysis. Pediatrics. 2015.(in press).
    1. Walton JM. Glycerin suppositories used prophylactically in premature infants (SUPP): a pilot randomized placebo-controlled trial. NCT02153606.
    1. Thabane L, Ma J, Chu R, Cheng J, Ismaila A, Rios LP, Robson R, Thabane M, Giangregorio L, Goldsmith CH. A tutorial on pilot studies: the what, why and how. BMC Med Res Methodol. 2010;10:1.
    1. Braga LH, Pemberton J, Heaman J, DeMaria J, Lorenzo AJ. Pilot randomized placebo-controlled trial to investigate the effect of antibiotic prophylaxis on the rate of urinary tract infection in infants with antenatal hydronephrosis. J Urol. 2014;191(5 Suppl):1501–7.
    1. Karagol BS, Zenciroglu A, Okumus N, Polin RA. Randomized controlled trial of slow vs rapid enteral feeding advancements on the clinical outcomes of preterm infants with birth weight 750–1250 g. JPEN J Parenter Enteral Nutr. 2013;37:223–8.
    1. Haiden N, Norooz F, Klebermass-Schrehof K, Horak AS, Jilma B, Berger A, Repa A. The effect of an osmotic contrast agent on complete meconium evacuation in preterm infants. Pediatrics. 2012;130:e1600–6.
    1. Research Electronic Data Capture (REDCap) Consortium.
    1. Gregory KE, Connolly TC. Enteral feeding practices in the NICU: results from a 2009 neonatal enteral feeding survey. Adv Neonatal Care. 2012;12(1):46–55.
    1. McMaster Children’s Hospital. NICU Nutrition summary guidelines. Revised July 2012.
    1. Premji SS, McNeil DA, Scotland J. Regional neonatal oral feeding protocol: changing the ethos of feeding preterm infants. J Perinat Neonatal Nurs. 2004;18:371–84.
    1. Julious SA. Sample size of 12 per group rule of thumb for a pilot study. Pharm Stat. 2005;4:287–91.
    1. Billingham SA, Whitehead AL, Julious SA. An audit of sample sizes for pilot and feasibility trials being undertaken in the United Kingdom registered in the United Kingdom Clinical Research Network database. BMC Med Res Methodol. 2013;13:104.
    1. Browne RH. On the use of a pilot sample for sample size determination. Stat Med. 1995;14:1933–40.
    1. Kenny SE, Tam PK, Garcia-Barcelo M. Hirschsprung’s disease. Semin Pediatr Surg. 2010;19:194–200.
    1. Schäppi MG, Staiano A, Milla PJ, Smith VV, Dias JA, Heuschkel R, Husby S, Mearin ML, Papadopoulou A, Ruemmele FM, Vandenplas Y, Koletzko S. A practical guide for the diagnosis of primary enteric nervous system disorders. J Pediatr Gastroenterol Nutr. 2013;57:677–86.
    1. Matthews TJ, MacDorman MF. Infant mortality statistics from the 2005 period linked birth/infant data set. Natl Vital Stat Rep. 2008;57:1.
    1. Mandy GT. Incidence and mortality of the premature infant. UpToDate last updated: July 24, 2013.
    1. IBM® SPSS® Statistics Version 21. 2012.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever